CPRX
CPRX
NASDAQ · Biotechnology

Catalyst Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$31.38
+0.00 (+0.00%)
Analyst Consensus
Hold
12
Analysts
Moderate
Coverage
Buy 6 50%
Hold 6 50%
Sell 0 0%
Price Target
Analyst Price Target +59.8% upside
Low Target $36.48
Average Target $50.13
High Target $69.47
Current Price $31.38
Current
$31.38
Target
$50.13
$36.48 $50.13 avg $69.47
Scenario Analysis
Bear Case
$36.48
16.3%
Low target
Base Case
$50.13
+59.8%
Avg target
Bull Case
$69.47
+121.4%
High target
Risk/Reward
7.5x
Highly favorable
Price in Context
52-Week High
$32.56
-3.6% from high
52-Week Low
$19.05
+64.7% from low
50-Day SMA
$23.76
+32.1% vs SMA
200-Day SMA
$22.30
+40.7% vs SMA
RSI (14)
48.5
Neutral
Target vs 52W High
$50.13
+54.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +12.0%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -44.6%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +190.4%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -6.1%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.5%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -37.5%